|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | (2018.01) |
| C07K 16/22 | (2013.01) | ||
| G01N 33/574 | (2006.01) | ||
| C07K 16/2818 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| G01N 33/57484 | (2013.01) | ||
| G01N2500/10 | (2013.01) | ||
| G01N2800/52 | (2013.01) |
| (11) | Number of the document | 3204516 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15848684.5 |
| Date of filing the European patent application | 2015-10-05 | |
| (97) | Date of publication of the European application | 2017-08-16 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/053933 |
| Date | 2015-10-05 |
| (87) | Number | WO 2016/057367 |
| Date | 2016-04-14 |
| (30) | Number | Date | Country code |
| 201462060230 P | 2014-10-06 | US | |
| 201562218277 P | 2015-09-14 | US | |
| 201562218624 P | 2015-09-15 | US |
| (72) |
HODI,F. Stephen , US
ZHOU, Jun , US
WU, Xinqi , US
|
| (73) |
Dana-Farber Cancer Institute, Inc. ,
450 Brookline Avenue, Boston, MA 02115-5450,
US
|
| (54) | ANGIOPOIETIN-2 BIOMARKERS PREDICTIVE OF ANTI-IMMUNE CHECKPOINT RESPONSE |
| ANGIOPOIETIN-2 BIOMARKERS PREDICTIVE OF ANTI-IMMUNE CHECKPOINT RESPONSE |